Overview

Efficacy of Adding Dexmedetomidine as an Adjuvant to Bupivacaine in TAP Block and Caudal Block

Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
0
Participant gender:
All
Summary
This study compares the efficacy of Dexmedetomidine as an adjuvant to Bupivacaine in Ultrasound Guided Transversus Abdominis Plane Block versus Caudal Block for post-operative analgesia in children undergoing congenital inguinal hernia repair especially to provide prolonged post-operative analgesia and decrease opioid consumption.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ain Shams University
Treatments:
Bupivacaine
Dexmedetomidine
Criteria
Inclusion Criteria:

- age 2-12 years

- Elective congenital inguinal hernia repair operation under general anaesthesia.

- Physical Status: ASA I and II Patients after taking written and informed consent from
the parents or care giver.

Exclusion Criteria:

- Refusal of procedure or participation in the study by parents.

- Physical status: ASA III or above.

- Children undergoing bilateral lower abdominal surgeries.

- Infection at site of injection.

- Congenital anomaly of the spine.

- History of developmental delay, neurological disease, skeletal deformities.

- History or evidence of coagulopathy.

- Allergies to drugs used (Bupivacaine 0.5%)( dexmedetomidine/prcedex)